NCT03636867View on ClinicalTrials.gov

Laboratory, Cellular and Molecular Determinants of Clinical Success in Diabetic Patients With Critical Limb Ischemia

CompletedOBSERVATIONAL
Enrollment

236

Participants

Timeline

Start Date

August 7, 2018

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Diabetes MellitusCritical Limb IschemiaCritical Lower Limb IschemiaDiabetic Foot
Interventions
OTHER

data and specimen collection

to identify laboratory, cellular and molecular determinants of clinical success after treatment, several clinical information and specimens will be collected by Authors from each patient

Trial Locations (1)

48010

Maria Cecilia Hospital, Cotignola

All Listed Sponsors
lead

Maria Cecilia Hospital

OTHER

NCT03636867 - Laboratory, Cellular and Molecular Determinants of Clinical Success in Diabetic Patients With Critical Limb Ischemia | Biotech Hunter | Biotech Hunter